Evidence of a modifying influence of heart glucosides on the development of breast cancer.
Patients on digitalis medication at the time of diagnosis of breast cancer seem to develop tumors that have a lower growth potential than do patients not on such medication. These tumors are photometrically characterized by small nuclei with lower DNA-RNA content and less variation in morphometric characteristics.
D001943:Breast Neoplasms / Q000473:pathology*; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D002467:Cell Nucleus / Q000473:pathology; D003201:Computers; D004074:Digitoxin / Q000627:therapeutic use*; D004077:Digoxin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D009362:Neoplasm Metastasis; D013223:Statistics as Topic
D002301:Cardiac Glycosides; D004077:Digoxin; D004074:Digitoxin